Compare Intuitive Surgical, Inc. (ISRG) vs iShares Core S&P 500 ETF (IVV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs iShares Core S&P 500 ETF — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while iShares Core S&P 500 ETF trades at $781.97 (market cap $897.20B). The key difference: iShares Core S&P 500 ETF is far larger — about 6.1× Intuitive Surgical, Inc.'s market cap, and iShares Core S&P 500 ETF is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and iShares Core S&P 500 ETF for 46 Days on average.
| ISRG | IVV | |
|---|---|---|
Market Cap | $146.76B | $897.20B |
Volume | 2,529,814 | 4,580,672 |
Sector | Health | Broad Market / Factor |
52-Week High | $592.85 | $782.58 |
52-Week Low | $332.02 | $634.93 |
Typical Hold Time | 84 Days | 46 Days |
Enterprise Value | $141.54B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.80, and has shown consistent revenue growth, reaching $10.06B in 2025. Analyst consensus is strongly bullish with a $480.78 price target, though the stock faces headwinds from slower procedure growth in some markets.
The outlook for ISRG remains positive due to its dominant position in robotic surgery, expanding international presence, and high recurring revenue. Key risks include competitive pressures, regulatory hurdles, and economic sensitivity affecting procedure volumes. With solid fundamentals and analyst support, the stock offers growth potential, but investors should monitor execution against these risks.
IVV, tracking the S&P 500, trades at $777.38, down 0.41% on the day, with a bullish technical signal from moving averages and neutral oscillators. Support lies at $775 and resistance at $780. Recent news highlights strong 2026 earnings growth expectations of 35% but a projected slowdown to 15% in 2027, with valuation debates ongoing amid index concentration risks.
The outlook remains cautiously optimistic given bullish technicals and Wall Street's long-term growth projections, but risks include profit growth deceleration, high market concentration, and interest rate sensitivity. IVV offers broad market exposure, yet investors should weigh slowing corporate earnings against historical bullish seasonal trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About iShares Core S&P 500 ETF
IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →
